Science misinformation alarms Francis Collins as he leaves top NIH job
By Nidhi Subbaraman,
Nature
| 12. 03. 2021
The genome project leader reflects on his 12 years at the helm of a juggernaut biomedical agency, and what lies ahead.
This month, Francis Collins will step down as director of the US National Institutes of Health (NIH) after more than 12 years leading the agency, the world’s biggest public funder of biomedical research. A former head of the Human Genome Project, he championed similar bold, big-budget science efforts, such as the All of Us Project, which aims to study health data from one million people. He led the NIH under three US presidents, steered it through a roiling pandemic, and faced myriad clashes over politics and biomedical science. Collins will stay on at the NIH to continue research in his lab. He spoke to Nature about some highlights of his time at the helm, and issues facing the agency in the future.
Which achievement will you cherish most?
It’s really hard to pick one. Maybe it’s where it was possible to bring together scientists of multiple disciplines and organize a truly bold, audacious project that would simply not have happened if one just counted on it coming together passively. I’m thinking of the BRAIN Initiative. I’m thinking of what...
Related Articles
By Darren Incorvaia, Fierce Biotech | 05.28.2025
An international group of gene editing leaders has put out a call for a 10-year ban on heritable human genome editing (HHGE), extending a moratorium that was first proposed in the fallout of a Chinese researcher’s widely decried use of...
Last week, May 21–23, a broad range of experts gathered in Boston to discuss the future of powerful biotechnologies with the potential to change what it means to be human. The fourth in a series of international Summits on human genome editing, this event was organized by the Global Observatory for Genome Editing, which “seeks to expand the range of questions arising at the frontiers of emerging biotechnologies … and fosters international, interdisciplinary, and cross-sectoral dialogue.” Like previous Summits...
By Caiwei Chen and Antonio Regalado , MIT Technology Review | 05.23.2025
Since the Chinese biophysicist He Jiankui was released from prison in 2022, he has sought to make a scientific comeback and to repair his reputation after a three-year incarceration for illegally creating the world’s first gene-edited children.
While he has...
By Kevin Davies, Genetic Engineering & Biotechnology News | 05.21.2025
This week a diverse group of researchers, bioethicists, publishers and theologians, are gathering in Cambridge, Massachusetts, to extend and expand the rolling debate about the merits of human heritable genome editing (HHGE). The international summit is being hosted by the...